Background Social media may influence children and young people’s health behaviour, including cigarette and e-cigarette use. Methods We analysed data from participants aged 10–25 years in the UK ...

Background The integration of artificial intelligence (AI) into critical care offers significant potential to enhance early ...

The National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Correspondence to Dr Chris Kosmidis, ...

3 National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK Correspondence to Professor Jennifer K Quint, National Heart and Lung Institute, Imperial College ...

Background Tobacco smoking is a leading behavioural risk factor for death in the UK, contributing to deaths from cardiovascular disease, chronic respiratory diseases and common infectious diseases. 1 ...

Dynamic lung volumes (forced vital capacity, forced expiratory volume in 0·5 second and in 1·0 second), static lung volumes (total lung capacity, functional residual capacity, residual volume), and ...

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term complication of acute pulmonary embolism (PE). We aimed to evaluate the impact of a symptom screening ...

Background Exacerbations of respiratory conditions including asthma are amongst the most common causes of emergency hospital attendances, but numerous pulmonary and extra-pulmonary comorbidities can ...

Background Systemic sclerosis (SSc) is a heterogeneous disease with frequently associated interstitial lung disease (SSc-ILD). We aimed to determine the prognostic potential of phenotyping patients ...

Introduction and Objective Severe asthma in children is a heterogenous disease resulting in significant morbidity and health care utilisation. The disease is driven by type 2/allergic inflammation.

Introduction Identifying acute hypercapnic respiratory failure is crucial in the initial management of acute exacerbations of COPD. Guidelines recommend obtaining arterial blood samples but these are ...

2 Research and Early Development, Respiratory and Immunology, BioPharmaceuticals RandD, AstraZeneca, Cambridge, UK 3 Respiratory and Immunology, Biometrics and Statistical Innovation, Late Respiratory ...